Press Release
Formerly PCRN: As part of the integration of PCRN into Momentum, this content now sits within the Momentum website. Two of New Zealand’s leading clinical research companies, Lakeland Clinical Trials Group and Southern Clinical Trials Group, have partnered with Pencarrow Private Equity, which has acquired a significant stake in both organisations.
October 21, 2021
•3 minutes

Connect with us
If you are keen to explore how Momentum can help you with your next clinical trial, them please reach out to us here.
ContactBen Harman’s considerable experience in relevant aspects of the healthcare sector including driving business growth, building a brand, and his understanding of clinical trial opportunities, will be invaluable to support PCRN moving forward.
The founders of Lakeland Clinical Trials Group and the Southern Clinical Trials Group will remain in their respective executive roles and are shareholders of the new entity. In addition, Dr Michael Williams will be PCRN’s Medical Director, with Dr Simon Carson as Medical Advisor; Julia Mathieson and Philippa Williams will be joint Chief Operating Officers of the combined group, and both Julia Mathieson and Michael Williams will join PCRN’s Board. PCRN will continue its close relationship with Paratus Clinical in Australia.
New Zealand locations
Australian locations
2026 © Momentum Clinical Research